Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH
2010 ◽
Vol 45
(7)
◽
pp. 750-757
◽
2009 ◽
Vol 22
(10)
◽
2003 ◽
Vol 17
(1)
◽
pp. 16-21
◽
2011 ◽
Vol 5
(5)
◽
pp. 402-406
◽
2007 ◽
Vol 375
(6)
◽
pp. 401-406
◽
Keyword(s):
2011 ◽
Vol 487
(1)
◽
pp. 99-102
◽